Newsgroup: it.salute
Titolo: Farmaci mortali...

Bayer «ha venduto farmaci a rischio Aids»
In Giappone, a Hong Kong, in Argentina e a Taiwan centinaia di persone sono
morte di Aids - gli ultimi nel '96 - per aver assunto farmaci che li
avrebbero dovuti aiutare a curare l'emofilia. Questa la denuncia del «New
York Times», che nell'edizione di ieri accusa senza mezzi termini l'azienda
farmaceutica Cutter Biological, segmento del gruppo tedesco Bayer, di non
aver ritirato dai mercati asiatici e latinoamericani il «Factor VIII
Concentrate».
-- 
G. Paolo Vanoli (I2VGP) Consulente in Scienza della Nutrizione e Medicine
Biologico Naturali
"prima della "Pace" occorre avere GIUSTIZIA, perche' non esiste pace senza
Giustizia"

 Concentrate».
Oh, cacchio, ma non sei che tu sostieni che l'AIDS non esiste ?
ancrea

 Oh, cacchio, ma non sei che tu sostieni che l'AIDS non esiste ?
Lui sostiene che l' AIDS esista, ma che non sia causato dal virus HIV, 
ma da altri fattori...
-- 
Torquemada.
"Everything is possible if you wish hard enough."
James Matthew Barrie, Peter Pan

 ma da altri fattori...
Pero' sostenendo che non e' virale  e trasmissibile, come fa ad accusare gli
emoderivati ?
andrea

 emoderivati ?
Lui sostiene che sia trasmissibile, anzi "innescabile" da chi ne soffre 
a chi non ne soffre ma potenzialmente ne puo' soffrire, attraverso 
sangue etc.
Poi, io non sono Vanoli e Vanoli non sono io, io ti ho semplicemente 
detto quello che mi e' parso di capire dai suoi ragionamenti.


Bayer «ha venduto farmaci a rischio Aids»
La storia e' vecchia di piu' di vent' anni . 
complimenti per il copia e incolla dal fondo del barile 
C' e' semmai da chiedersi perche' il NYT  abbia rispolverato ancora una
volta questa storia 
===============================================
Company denies allegations of misconduct in the 1980s 
Leverkusen (May 23, 2003)
Bayer denies the allegations, expressed in an article in the New York Times,
of misconduct in the marketing of contaminated blood plasma products in the
mid-1980s. The decisions of the former U.S. subsidiary Cutter, like those
made by all other providers of such products some twenty years ago, were
based on the best scientific information available at the time and the state
of technology, and were consistent with the regulations in place. They
cannot be judged retrospectively on the information available today. 
After it had been discovered that it was possible for HIV to be transmitted
by these hemophilia medicines, a new procedure was developed in which the
virus was killed by heat treatment. However, there was initially great
skepticism in the industry as well as among scientists, physicians,
hemophilia societies, and patients about whether the heat treatment would
also compromise the efficacy of the product. Once this concern had been
cleared and the U.S. authorities had granted marketing approval, Cutter
implemented the new procedure. Until that time, however, it was not possible
to halt production of the untreated medicine despite the risks involved,
because the product was vitally important for the patients' well-being.
Production of the product finally came to an end in August 1984 and from
June 1985 on, only heat-treated product was distributed. 
The fact criticized by the New York Times in its article, that untreated
medicine continued to be sold overseas while only the new version was
available on the U.S. market, is due to the registration procedures of local
authorities. Bayer was unable to market the treated product before approval
had been granted, yet nonetheless had to ensure an uninterrupted supply of
medicine to hemophilia patients. 
Bayer therefore emphatically denies allegations that it deliberately exposed
patients in some countries to the risk of infection with HIV. Bayer acted
responsibly, ethically and humanely at all times. The infection of
individual hemophiliacs was a tragic development that could not, even with
hindsight, have been avoided. 
In recent years, Bayer has repeatedly expressed its deep sorrow and sympathy
to those hemophiliacs who were affected and the hemophilia community as a
whole, and has contributed to compensation funds set up to help victims in
various countries in which arrangements were made. 
==============================================
 
-- 
sgas


perche' le multinazionali continuano anche dopo 20 anni a fare le stesse
cose,.....della salute umana ed animale a loro NON non ne frega NULLA !
